IQVIA (NYSE:IQV – Get Free Report) had its price objective decreased by equities researchers at Evercore ISI from $275.00 to $250.00 in a report released on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the medical research company’s stock. Evercore ISI’s price target would suggest a potential upside of 11.91% from the […]